On RAF-MEK-ERK, it has been shown that CK2α overexpression cells resulted in MEK deactivation in NIH 3T3 [13], and CK2α and CK2α' silencing led to increases in ERK1/2 phosphorylation in human glioblastoma cell lines [14]. The gene discussed is MAP2K7; the disease is glioblastoma.